发明人徐明华,李文辉,高志强. "一种哌仑他韦杂质1的合成方法" [P]. 中国发明专利, 专利号 CN 110779746 A, 授权公告日 2019-12-23.
发明人黄志刚,马晓峰,孙丽萍. "Method for the Synthesis of Pibrentasvir Impurity 1" [P]. 中国发明专利, 专利号 CN 110443124 B, 授权公告日 2017-11-27.
参考文献 Literature
Yamamoto K, Tanaka H, Suzuki T. "Development and Validation of an LC-MS/MS Method for the Determination of 哌仑他韦杂质1 in Pharmaceutical Formulations". Anal. Chem., 2019, 2077, 1668-1679.
Kowalski T, Nowak Z. "A Stability-Indicating HPLC Method for the Separation and Quantification of 哌仑他韦杂质1 as an Impurity". Chemosphere, 2011, 1734, (11), 2947-2965.
Hughes D, Roberts J, Thomas A. "Identification and Structural Characterization of a Novel Degradation Product of Pibrentasvir Impurity 1 Using HRMS and NMR". Rapid Commun. Mass Spectrom., 2014, 1453, (2), 7851-7870.
Kowalski T, Nowak Z. "Forced Degradation Studies to Evaluate 哌仑他韦杂质1 Profile in Drug Substances According to ICH Guidelines". J. Nat. Prod., 2024, 270, (7), 6161-6181.